Abstract
The slow AV nodal pathway was ablated selectively in a 62-year-old man with uncontrolled rapid atrial fibrillation. This resulted in a much slower ventricular response without the need for permanent pacing. The pathophysiology is discussed.
MeSH terms
-
Anti-Arrhythmia Agents / therapeutic use
-
Atrial Fibrillation / drug therapy
-
Atrial Fibrillation / physiopathology
-
Atrial Fibrillation / surgery*
-
Atrioventricular Node / surgery*
-
Catheter Ablation*
-
Flecainide / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Ventricular Function / physiology
Substances
-
Anti-Arrhythmia Agents
-
Flecainide